Literature DB >> 24476704

Comparison of gluteal perforator flaps and gluteal fasciocutaneous rotation flaps for reconstruction of sacral pressure sores.

Yen-Chou Chen1, Eng-Yen Huang2, Pao-Yuan Lin3.   

Abstract

BACKGROUND AND AIM: The gluteus maximus myocutaneous flap was considered the workhorse that reconstructed sacral pressure sores, but was gradually replaced by fasciocutaneous flap because of several disadvantages. With the advent of the perforator flap technique, gluteal perforator (GP) flap has gained popularity nowadays. The aim of this study was to compare the complications and outcomes between GP flaps and gluteal fasciocutaneous rotation (FR) flaps in the treatment of sacral pressure sores.
METHODS: Between April 2007 and June 2012, 63 patients underwent sacral pressure sore reconstructions, with a GP flap used in 31 cases and an FR flap used in 32 cases. Data collected on the patients included patient age, gender, co-morbidity for being bedridden and follow-up time. Surgical details collected included the defect size, operative time and estimated blood loss. Complications recorded included re-operation, dehiscence, flap necrosis, wound infection, sinus formation, donor-site morbidity and recurrence. The complications and clinical outcomes were compared between these two groups.
RESULTS: We found that there was no significant difference in patient demographics, surgical complications and recurrence between these two groups. In gluteal FR flap group, all recurrent cases (five) were treated by reuse of previous flaps.
CONCLUSIONS: Both methods are comparable, good and safe in treating sacral pressure sores. Gluteal FR flap can be performed without microsurgical dissection, and re-rotation is feasible in recurrent cases. The authors suggest using gluteal FR flaps in patients with a high risk of sore recurrence.
Copyright © 2013 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gluteal fasciocutaneous rotation flap; Gluteal perforator flap; Sacral pressure sore reconstruction

Mesh:

Year:  2014        PMID: 24476704     DOI: 10.1016/j.bjps.2013.12.029

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  6 in total

1.  Recurrence rate after pressure ulcer reconstruction in patients with spinal cord injury in patients under control by a plastic surgery and physical medicine and rehabilitation team.

Authors:  Nurdan Paker; Derya Buğdaycı; Gökşen Gökşenoğlu; Dilber Akbaş; Taner Korkut
Journal:  Turk J Phys Med Rehabil       Date:  2018-11-06

2.  3D Volumetric Modeling and Microvascular Reconstruction of Irradiated Lumbosacral Defects after Oncologic Resection.

Authors:  Emilio Garcia-Tutor; Marco Romeo; Michael P Chae; David J Hunter-Smith; Warren Matthew Rozen
Journal:  Front Surg       Date:  2016-12-13

3.  Dual Reconstruction of Lumbar and Gluteal Defects with Freestyle Propeller Flap and Muscle Flap.

Authors:  Mohamed A Ellabban; Alexander Wyckman; Islam Abdelrahman; Ingrid Steinvall; Moustafa Elmasry
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-01-26

4.  Combined V-Y Fasciocutaneous Advancement and Gluteus Maximus Muscle Rotational Flaps for Treating Sacral Sores.

Authors:  Hyun Ho Han; Eun Jeong Choi; Suk Ho Moon; Yoon Jae Lee; Deuk Young Oh
Journal:  Biomed Res Int       Date:  2016-06-06       Impact factor: 3.411

5.  Application of gluteus maximus fasciocutaneous V-Y advancement flap combined with resection in sacrococcygeal pressure ulcers: A CONSORT-compliant article.

Authors:  Xing Liu; Wan Lu; Yidong Zhang; Yun Liu; Xinghua Yang; Sheng Liao; Zhongrong Zhang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

6.  Clover-Style Fasciocutaneous Perforator Flap for Reconstruction of Massive Sacral Pressure Sores.

Authors:  Jian Cheng; Qi Zhang; Shiming Feng; Xiaodong Wu; Weiling Huo; Yong Ma; Jianping Cai; Mingming Liu
Journal:  Ann Plast Surg       Date:  2021-01       Impact factor: 1.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.